Contraceptive practices in women with sickle-cell disease

Contraceptive practices in women with sickle-cell disease

Author Carvalho, Natalia da Silva Autor UNIFESP Google Scholar
Braga, Josefina Pellegrini Autor UNIFESP Google Scholar
Barbieri, Marcia Autor UNIFESP Google Scholar
Torloni, Maria Regina Autor UNIFESP Google Scholar
Figueiredo, Maria Stella Autor UNIFESP Google Scholar
Guazzelli, Cristina Aparecida Falbo Autor UNIFESP Google Scholar
Abstract This was a cross-sectional study of sexually active women with sickle-cell disease (SCD) managed at SAo Paulo Federal University during a one-year period. A total of 54 women were included. Mean age was 32.0 (11.2, standard deviation) years and almost 95% were black or of mixed racial ancestry. Almost 80% reported a history of multiple blood transfusions, 50% had kidney disease and 17% had a history of thrombosis. Over 80% of them had used some form of contraception, mostly combined hormonal contraceptive (52%) or progestin-only contraceptives (46%). Although most women had multiple comorbidities which would contraindicate the use of combined hormonal contraceptives, this was the most popular method used by them. We did not identify an association between the use of combined hormonal contraceptives and major complications. Larger, prospective studies are needed to evaluate the use and the effects of contraceptive methods in women with SCD.
Keywords Hormonal oral contraceptive
combined oral contraceptives
sickle-cell anaemia
xmlui.dri2xhtml.METS-1.0.item-coverage Philadelphia
Language English
Date 2017
Published in Journal Of Obstetrics And Gynaecology. Philadelphia, v. 37, n. 1, p. 74-77, 2017.
ISSN 0144-3615 (Sherpa/Romeo, impact factor)
Publisher Taylor & Francis Inc
Extent 74-77
Access rights Closed access
Type Article
Web of Science ID WOS:000395199200016

Show full item record


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)




My Account